These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23665160)

  • 101. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
    Tayebi N; Walker J; Stubblefield B; Orvisky E; LaMarca ME; Wong K; Rosenbaum H; Schiffmann R; Bembi B; Sidransky E
    Mol Genet Metab; 2003 Jun; 79(2):104-9. PubMed ID: 12809640
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
    J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Retinal thinning in Gaucher disease patients and carriers: results of a pilot study.
    McNeill A; Roberti G; Lascaratos G; Hughes D; Mehta A; Garway-Heath DF; Schapira AH
    Mol Genet Metab; 2013 Jun; 109(2):221-3. PubMed ID: 23639447
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
    Nalls MA; Duran R; Lopez G; Kurzawa-Akanbi M; McKeith IG; Chinnery PF; Morris CM; Theuns J; Crosiers D; Cras P; Engelborghs S; De Deyn PP; Van Broeckhoven C; Mann DM; Snowden J; Pickering-Brown S; Halliwell N; Davidson Y; Gibbons L; Harris J; Sheerin UM; Bras J; Hardy J; Clark L; Marder K; Honig LS; Berg D; Maetzler W; Brockmann K; Gasser T; Novellino F; Quattrone A; Annesi G; De Marco EV; Rogaeva E; Masellis M; Black SE; Bilbao JM; Foroud T; Ghetti B; Nichols WC; Pankratz N; Halliday G; Lesage S; Klebe S; Durr A; Duyckaerts C; Brice A; Giasson BI; Trojanowski JQ; Hurtig HI; Tayebi N; Landazabal C; Knight MA; Keller M; Singleton AB; Wolfsberg TG; Sidransky E
    JAMA Neurol; 2013 Jun; 70(6):727-35. PubMed ID: 23588557
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Cerebrospinal fluid biomarkers in Parkinson disease.
    Parnetti L; Castrioto A; Chiasserini D; Persichetti E; Tambasco N; El-Agnaf O; Calabresi P
    Nat Rev Neurol; 2013 Mar; 9(3):131-40. PubMed ID: 23419373
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The link between the GBA gene and parkinsonism.
    Sidransky E; Lopez G
    Lancet Neurol; 2012 Nov; 11(11):986-98. PubMed ID: 23079555
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.
    Goker-Alpan O; Masdeu JC; Kohn PD; Ianni A; Lopez G; Groden C; Chapman MC; Cropp B; Eisenberg DP; Maniwang ED; Davis J; Wiggs E; Sidransky E; Berman KF
    Brain; 2012 Aug; 135(Pt 8):2440-8. PubMed ID: 22843412
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Olfactory dysfunction in Parkinson disease.
    Doty RL
    Nat Rev Neurol; 2012 May; 8(6):329-39. PubMed ID: 22584158
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.
    Postuma RB; Aarsland D; Barone P; Burn DJ; Hawkes CH; Oertel W; Ziemssen T
    Mov Disord; 2012 Apr; 27(5):617-26. PubMed ID: 22508280
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Tone discrimination as a window into acoustic perceptual deficits in Parkinson's disease.
    Troche J; Troche MS; Berkowitz R; Grossman M; Reilly J
    Am J Speech Lang Pathol; 2012 Aug; 21(3):258-63. PubMed ID: 22442285
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Retinal thickness in Parkinson's disease.
    Archibald NK; Clarke MP; Mosimann UP; Burn DJ
    Parkinsonism Relat Disord; 2011 Jul; 17(6):431-6. PubMed ID: 21454118
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Transcranial ultrasound as a risk marker for Parkinson's disease.
    Berg D
    Mov Disord; 2009; 24 Suppl 2():S677-83. PubMed ID: 19877199
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
    Sidransky E; Nalls MA; Aasly JO; Aharon-Peretz J; Annesi G; Barbosa ER; Bar-Shira A; Berg D; Bras J; Brice A; Chen CM; Clark LN; Condroyer C; De Marco EV; Dürr A; Eblan MJ; Fahn S; Farrer MJ; Fung HC; Gan-Or Z; Gasser T; Gershoni-Baruch R; Giladi N; Griffith A; Gurevich T; Januario C; Kropp P; Lang AE; Lee-Chen GJ; Lesage S; Marder K; Mata IF; Mirelman A; Mitsui J; Mizuta I; Nicoletti G; Oliveira C; Ottman R; Orr-Urtreger A; Pereira LV; Quattrone A; Rogaeva E; Rolfs A; Rosenbaum H; Rozenberg R; Samii A; Samaddar T; Schulte C; Sharma M; Singleton A; Spitz M; Tan EK; Tayebi N; Toda T; Troiano AR; Tsuji S; Wittstock M; Wolfsberg TG; Wu YR; Zabetian CP; Zhao Y; Ziegler SG
    N Engl J Med; 2009 Oct; 361(17):1651-61. PubMed ID: 19846850
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Stages in the development of Parkinson's disease-related pathology.
    Braak H; Ghebremedhin E; Rüb U; Bratzke H; Del Tredici K
    Cell Tissue Res; 2004 Oct; 318(1):121-34. PubMed ID: 15338272
    [TBL] [Abstract][Full Text] [Related]  

  • 115. An essay on the shaking palsy. 1817.
    Parkinson J
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):223-36; discussion 222. PubMed ID: 11983801
    [No Abstract]   [Full Text] [Related]  

  • 116. Predicting parkinsonism: new opportunities from Gaucher disease.
    Lopez G; Sidransky E
    Mol Genet Metab; 2013 Jul; 109(3):235-6. PubMed ID: 23665160
    [No Abstract]   [Full Text] [Related]  

  • 117. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene.
    Sidransky E; Sherer DM; Ginns EI
    Pediatr Res; 1992 Oct; 32(4):494-8. PubMed ID: 1437405
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Type 2 gaucher disease: an expanding phenotype.
    Tayebi N; Stone DL; Sidransky E
    Mol Genet Metab; 1999 Oct; 68(2):209-19. PubMed ID: 10527671
    [No Abstract]   [Full Text] [Related]  

  • 119. Parkinsonism in Gaucher's disease type 1: ten new cases and a review of the literature.
    Kraoua I; Stirnemann J; Ribeiro MJ; Rouaud T; Verin M; Annic A; Rose C; Defebvre L; Réménieras L; Schüpbach M; Belmatoug N; Vidailhet M; Sedel F
    Mov Disord; 2009 Jul; 24(10):1524-30. PubMed ID: 19513999
    [TBL] [Abstract][Full Text] [Related]  

  • 120. New perspectives in type 2 Gaucher disease.
    Sidransky E
    Adv Pediatr; 1997; 44():73-107. PubMed ID: 9265968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.